← Back to Patent Explorer
US4080328A Expired / Lapsed US ⏱️ 0.0 years remaining

N-substituted heterocyclic derivatives and preparation thereof

Assignee: Sumitomo Chemical Co Ltd
•
Filing: 1974-06-28
•
Granted: 1978-03-21
•
Expires: 1994-06-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel N-substituted heterocyclic derivatives represented by the formula, ##STR1## wherein R is hydrogen or lower alkanoyl; R 1 is hydrogen, lower alkyl, lower alkoxy, halogen, nitro, trifluoromethyl, amino or N-lower alkanoylamino; R 2 is hydrogen, halogen, amino or N-lower alkanoylamino; W is oxygen, sulfur, sulfinyl or sulfonyl; and Y is ##STR2## (wherein R 3 is hydrogen, lower alkyl or lower alkanoyl; and R 4 is hydrogen, halogen or lower alkyl), and pharmaceutically acceptable salts thereof, which have excellent anti-inflammatory, analgesic, sedative, anti-convulsive or anti-hypertensive activities.

Inventors

  • 👤 Isamu Maruyama
  • 👤 Masaru Nakao
  • 👤 Kikuo Sasajima
  • 👤 Shigeho Inaba
  • 👤 Izumi Yanagihara
  • 👤 Hisao Yamamoto

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 16:25
CPC Classifications
C; C07; C07D; C07D401/00; C07D401/02; C07D401/06; C07D401/04; C07D401/12; C07D401/14; C07D405/00; C07D405/14

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 55 words
A chemical compound selected from the group consisting of a benzimidazoline derivative having the formula: ##STR11## and the therapeutically active acid addition salts thereof, wherein R 1 is a member selected from the group consisting of hydrogen, halo, and loweralkoxy; and R 2 is a member selected from the group consisting of hydrogen and halo.
Claim 2
Dependent Claim 55 words
A chemical compound selected from the group consisting of a benzimidazoline derivative having the formula: ##STR11## and the therapeutically active acid addition salts thereof, wherein R 1 is a member selected from the group consisting of hydrogen, halo, and loweralkoxy; and R 2 is a member selected from the group consisting of hydrogen and halo.
Claim 3
Dependent Claim 1 words
1-{1-[3-p-Fluorophenoxy-2-hydroxypropyl]-4-piperidyl}-2-oxobenzimidazoline.
Claim 4
Dependent Claim 1 words
1-{1-[3-p-Fluorophenoxy-2-hydroxypropyl]-4-piperidyl}-2-oxobenzimidazoline.

References Cited (Backward Citations)

FR3043E Cited
CA794351A Cited
DE1043141B Cited
US3196157A Cited
GB1043141A Cited
US3238216A Cited
BE663431A Cited
US3225052A Cited
NL7211619A Cited
US3818017A Cited
US3894030A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-03-20 1981-09-19 1982-03-21 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-03-20 1985-09-19 1986-03-21 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-03-20 1989-09-19 1990-03-21 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag